The lower-priced version of Repatha was introduced a year ago in answer to market research suggesting that three-quarters of Medicare patients prescribed a PCSK9 inhibitor never actually fill in ...

The results are very encouraging news for Amgen and Repatha, which is in a head-to-head marketing battle with Sanofi and Regeneron’s Praluent to be the dominant PCSK9 inhibitor. Both drugs have ...

Dutch clinical-stage drug developer NewAmsterdam Pharma saw its shares close up 41% at $26.19 yesterday on positive research ...

PCSK9 inhibitors block these proteins from breaking ... monoclonal antibodies alirocumab (Praluent) and evolocumab (Repatha) and the injectable small interfering RNA agent inclisiran (Leqvio).

NewAmsterdam Pharma said Tuesday its cholesterol drug lowered the risk of major cardiovascular events and the biotech stock ...

Inject Repatha only on the day of your scheduled dose, not a day early. But you may be able to shift your usual injection time of day. Repatha has received Food and Drug Administration (FDA ...

In adults with cardiovascualr disease or high cholesterol, doctors prescribe subcutaneous (below the skin) Repatha injections every 2 weeks or monthly. To find out if a Medicare plan covers ...

Almost all (95%) Medicare drug plans cover Repatha. This includes standalone Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage. Repatha is a brand ...

Doctors typically follow recent cholesterol guidelines that recommend limiting saturated fats, instead of targeting a specific daily limit. You may consider limiting those unhealthy fats to 10% or ...